miR‑30a Inhibits Epithelial‑mesenchymal Transition and Metastasis in Triple‑negative Breast Cancer by Targeting ROR1

Oncology Reports - Greece
doi 10.3892/or.2018.6379
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

miR-573 Inhibits Prostate Cancer Metastasis by Regulating Epithelial-Mesenchymal Transition

Oncotarget
Oncology
2015English

miR-30a Inhibits the Biological Function of Breast Cancer Cells by Targeting Notch1

International Journal of Molecular Medicine
MedicineGenetics
2017English

GATA3 Inhibits Breast Cancer Metastasis Through the Reversal of Epithelial-Mesenchymal Transition

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2010English

Novel Diphenylamine Analogs Induce Mesenchymal to Epithelial Transition in Triple Negative Breast Cancer

Frontiers in Oncology
Cancer ResearchOncology
2019English

miR-125a-5p Inhibits Colorectal Cancer Cell Epithelial–mesenchymal Transition, Invasion and Migration by Targeting TAZ

OncoTargets and Therapy
OncologyPharmacology
2019English

miR‑199b‑5p Inhibits Triple Negative Breast Cancer Cell Proliferation, Migration and Invasion by Targeting DDR1

Oncology Letters
Cancer ResearchOncology
2018English

Baicalin Inhibits the Metastasis of Highly Aggressive Breast Cancer Cells by Reversing Epithelial-To-Mesenchymal Transition by Targeting Β-Catenin Signaling

Oncology Reports
MedicineCancer ResearchOncology
2017English

An in Vitro–in Vivo Model of Epithelial Mesenchymal Transition in Triple Negative Breast Cancer

Drug Discovery Today: Disease Mechanisms
2012English

Long Non-Coding RNA ZEB2-AS1 Promotes the Proliferation, Metastasis and Epithelial Mesenchymal Transition in Triple-Negative Breast Cancer by Epigenetically Activating ZEB2

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy